Published by
@ShahidNShah
@ShahidNShah
February 13 to February 15, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
Embrace the evolving late-stage gene therapy landscape with 10+ FDA and EMA approvals in the past year, expecting more decisions by early 2024. As the number of active clinical trials surges, emphasis on comparability by drug developers and regulators intensifies. The 4th Gene Therapy Comparability Summit returns in February 2024, building on lessons from 2023 approvals. Join industry experts to navigate effective comparability studies, mitigate costly delays in clinical programs, and enhance approval prospects. Explore strategies to de-risk and streamline your path to success at this pivotal summit from Tuesday, February 13, 2024, at 9:00 am to Thursday, February 15, 2024, at 3:00 pm.
Read on genetherapy-comparability.com
Continue reading at genetherapy-comparability.com
February 13 to February 15, 2024
Hilton Boston Park Plaza, 50 Park Plaza, Boston, Massachusetts, 02116, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am